13 Thromboembolic, Bleeding, and Mortality Risks among Patients with Nonvalvular Atrial Fibrillation Treated with Dual Antiplatelet Therapy versus Oral Anticoagulants: A Population-Based Study.

14 Economic evaluation of the use of non-Vitamin K oral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: A modelling analysis using the healthcare system in the Netherlands

15 Platelet-rich plasma plays an antibacterial, anti-inflammatory and cell proliferation-promoting role in an in vitro model for diabetic infected wounds

16 The association between platelet indices and deep surgical site infection after open induction internal fixation for traumatic limb fractures

17 Platelet reactivity in diabetic patients with invasive Klebsiella pneumoniae liver abscess syndrome

18 Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma

19 Platelet-rich plasma plays an antibacterial, anti-inflammatory and cell proliferation-promoting role in an in vitro model for diabetic infected wounds

20 The association between platelet indices and deep surgical site infection after open induction internal fixation for traumatic limb fractures

21 Platelet reactivity in diabetic patients with invasive Klebsiella pneumoniae liver abscess syndrome

22 Preoperative Neutrophil-to-Lymphocyte Ratio Plus Platelet-to-Lymphocyte Ratio Predicts the Outcomes after Curative Resection for Hepatocellular Carcinoma

23 Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma

24 Porous Co<inf>3</inf>O<inf>4</inf> nanoplatelets as efficient catalyst precursor for hydrogen generation from the hydrolysis of alkaline sodium borohydride solution

25 Combination therapy targeting platelet activation and virus replication protects mice against lethal influenza pneumonia.

26 Ir-6: A Novel Iridium (III) Organometallic Derivative for Inhibition of Human Platelet Activation

27 Association of glycemic status and interferon-γ production with leukocytes and platelet indices alterations in type2 diabetes

28 Relationship of Platelet Reactivity and Inflammatory Markers to Recurrent Adverse Events in Patients with ST-Elevation Myocardial Infarction.

29 Analysis of cytokine profile and growth factors in platelet-rich plasma obtained by open systems and commercial columns.

30 Septic shock during platelet transfusion in a patient with acute myeloid leukaemia.

31 Does the timing of aspirin administration influence its antiplatelet effect - review of literature on chronotherapy.

32 Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study.

33 The use of stromal vascular fraction (SVF), platelet-rich plasma (PRP) and stem cells in the treatment of osteoarthritis: an overview of clinical trials

34 Mesenchymal Stem Cells and Platelet Gel Improve Bone Deposition within CAD-CAM Custom-Made Ceramic HA Scaffolds for Condyle Substitution

35 Comparison of Effects of Pulsed Electromagnetic Field Stimulation on Platelet-Rich Plasma and Bone Marrow Stromal Stem Cell Using Rat Zygomatic Bone Defect Model.

36 The contribution of platelet studies to the understanding of disease mechanisms in complex and monogenetic neurological disorders

37 Experimental investigations of using MWCNTs and graphene nanoplatelets water-based nanofluids as coolants in PVT systems

38 Heat transfer and pressure drop investigation of graphene nanoplatelet-water and titanium dioxide-water nanofluids in a horizontal tube

39 Extracellular vesicles from CLEC2-activated platelets enhance dengue virus-induced lethality via CLEC5A/TLR2

40 Platelet function in HIV plus dengue coinfection associates with reduced inflammation and milder dengue illness

41 Comparative response of platelet fV and plasma fV to activated protein C and relevance to a model of acute traumatic coagulopathy.

42 Design, Synthesis and Anti-Platelet Aggregation Activity Study of Ginkgolide-1,2,3-triazole Derivatives

43 Platelet mitochondrial bioenergetic analysis in patients with nephropathies and non-communicable diseases: a new method.

44 Inherited platelet disorders in women.

45 Ultrasound-guided bilateral combined inguinal femoral and subgluteal sciatic nerve blocks for simultaneous bilateral below-knee amputations due to bilateral diabetic foot gangrene unresponsive to peripheral arterial angioplasty and bypass surgery in a coagulopathic patient on antiplatelet therapy with a history of percutaneous coronary intervention for ischemic heart disease: A case report

46 Micro-Nano Carbon Structures with Platelet, Glassy and Tube-Like Morphologies.

47 Mean platelet volume, neutrophil to lyphocyte ratio and platelet to lymphocyte ratio in psoriasis

48 Collagen can selectively trigger a platelet secretory phenotype via glycoprotein VI.

49 Reducing demand uncertainty in the platelet supply chain through artificial neural networks and ARIMA models.

50 Antiplatelet therapy and anticoagulation in patients with hypertension.

51 Can intra-articular injection of freeze-dried platelet-derived factor concentrate regenerate articular cartilage in the knee joint?

52 Effects of the graphene nanoplatelets reinforced interphase on mechanical properties of carbon fibre reinforced polymer – A multiscale modelling study

53 Microstructure and nanoindentation behavior of Cu composites reinforced with graphene nanoplatelets by electroless co-deposition technique.

54 An Overview of Metal Matrix Nanocomposites Reinforced with Graphene Nanoplatelets; Mechanical, Electrical and Thermophysical Properties

55 Antiplatelet therapy and coronary artery bypass grafting: Protocol for a systematic review and network meta-analysis.

56 Relationship of Hypertensive Retinopathy with Mean Platelet Volume Among Hypertensive Patients.

57 The Effect of Silymarin Flavonolignans and Their Sulfated Conjugates on Platelet Aggregation and Blood Vessels Ex Vivo.

58 Platelet-Derived Growth Factor Receptor and Ionizing Radiation in High Grade Glioma Cell Lines.

59 Knee Osteoarthritis Injection Choices: Platelet- Rich Plasma (PRP) versus Hyaluronic Acid (A one-year randomized clinical trial)

60 A precision medicine approach to defining the impact of doxorubicin on the bioenergetic-metabolite interactome in human platelets.

61 A precision medicine approach to defining the impact of doxorubicin on the bioenergetic-metabolite interactome in human platelets

62 The Metabolites of the Dietary Flavonoid Quercetin Possess Potent Antithrombotic Activity, and Interact with Aspirin to Enhance Antiplatelet Effects.

63 [Relation of Functional Activity of Platelets to Prognosis of Unfavorable Cardiovascular Events in Patients with Acute Coronary Syndrome. Results of a Registry Study].

64 Platelet count and mean volume in acute stroke: a systematic review and meta-analysis.

65 Impact of Extravasated Platelet Activation and Podoplanin-positive Cancer-associated Fibroblasts in Pancreatic Cancer Stroma.

66 Effects of diltiazem on platelet activation and cytosolic calcium during percutaneous transluminal coronary angioplasty.

67 Comparison of Connective Tissue Graft and Platelet Rich Fibrin as Matrices in A Novel Papillary Augmentation Access: A Randomized Controlled Clinical Trial.

68 High-Efficiency Production of Large-Size Few-Layer Graphene Platelets via Pulsed Discharge of Graphite Strips.

69 Functionalising Collagen-Based Scaffolds With Platelet-Rich Plasma for Enhanced Skin Wound Healing Potential

70 Comparative evaluation of platelet rich plasma in socket healing and bone regeneration after surgical removal of impacted mandibular third molars

71 Expression of CXCR4 in cord blood-derived CD133+ cells treated with platelet micro-particles.

72 Perioperative antithrombotic (antiplatelet and anticoagulant) therapy in urological practice: a critical assessment and summary of the clinical practice guidelines.

73 Can mean platelet volume be used as a biomarker for asthma?

74 The diagnostic value of a globulin/platelet model for evaluating liver fibrosis in chronic hepatitis B patients

75 Head-to-Head Comparison of Consensus-Recommended Platelet Function Tests to Assess P2Y Inhibition-Insights for Multi-Center Trials.

76 Effectiveness and safety of autologous platelet-rich plasma therapy with total contact casting versus total contact casting alone in treatment of trophic ulcer in leprosy: An observer-blind, randomized controlled trial.

77 Platelet Function and Therapeutic Applications in Dogs: Current Status and Future Prospects.

78 Comparative impact of platelet rich plasma and transforming growth factor-β on chondrogenic differentiation of human adipose derived stem cells.

79 Anterior Cruciate Ligament Reconstruction with Platelet-Rich Plasma: A Systematic Review of Randomized Control Trials.

80 Impact of the different preparation methods to obtain autologous non‐activated platelet‐rich plasma (A‐PRP) and activated platelet‐rich plasma (AA‐PRP) in plastic surgery: Wound healing and hair regrowth evaluation

81 Platelet-Rich Plasma (PRP) is a Potential Self-Sourced Cognition Booster in Elderly Mice

82 The Number of Platelets in Patient's Blood Influences the Mechanical and Morphological Properties of PRP-Clot and Lysophosphatidic Acid Quantity in PRP

83 An open invitation on: Pathogen safety standard of human platelet lysate for regenerative medicine; beneficial use of PRP in treatment of musculoskeletal pathologies and newer challenges on vitamin B12 deficiency and metabolism- mediated thrombotic microangiopathy

84 Autologous platelet-rich plasma (CuteCell PRP) safely boosts in vitro human fibroblast expansion

85 Allogeneic platelet-rich plasma (PRP) is superior to platelets or plasma alone in stimulating fibroblast proliferation and migration, angiogenesis, and chemotaxis as relevant processes for wound healing

86 Use of Biomaterials Associated or not to the Platelet-Rich Plasma in Cranial Bone Defects. Microscopical Study in Dogs

87 The effect of oxLDL on microvesicle release from platelets, measured by a sensitive flow cytometry method.

88 BONE GRAFTING ENHANCED BY PLATELET-RICH PLASMA IN TREATMENT OF AVASCULAR NECROSIS OF FEMORAL HEAD

89 Platelet count is associated with sustained virological response rates in treatments for chronic hepatitis C.

90 Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.

91 Mean platelet volume may not be an independent prognostic factor in breast cancer patients with type 2 diabetes mellitus

92 CD133 <sup>+</sup> bone marrow stem cells (BMSC) control platelet activation – Role of ectoNTPDase-1 (CD39)

93 Targeting CD39 Toward Activated Platelets Reduces Systemic Inflammation and Improves Survival in Sepsis: A Preclinical Pilot Study

94 Evaluation of New Bone Formation Using Autogenous Tooth Bone Graft Combined with Platelet-Rich Fibrin in Calvarial Defects.

95 A Randomized Controlled Trial Comparing Platelet-Rich Plasma, Low-Level Laser Therapy, and Complex Decongestive Physiotherapy in Patients with Lower Limb Lymphedema.

96 Leptospira interrogans Bat proteins impair host hemostasis by fibrinogen cleavage and platelet aggregation inhibition.

97 Preactivated and disaggregated shape-changed platelets protect kidney against from ischemia-reperfusion injury in rat through attenuating inflammation reaction

98 Platelet-to-lymphocyte ratio is associated with prognosis in patients with Corona Virus Disease-19.

99 Decrease in 130 kDa- amyloid protein precursor protein (app) and APP protein ratio in schizophrenia platelets.

100 Intraosseous injections of platelet rich plasma for knee bone marrow lesions treatment: one year follow-up.

101 Platelet biology of the rapidly failing lung.

Keyword Connections

Journals

Research Groups

Bibliographies